DMC Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Sell |
5,626
-37
| -0.7% | -$6.87K | 0.81% | 37 |
|
|
2025
Q1 | $1.19M | Sell |
5,663
-3
| -0.1% | -$629 | 0.97% | 29 |
|
|
2024
Q4 | $1.01M | Sell |
5,666
-50
| -0.9% | -$8.89K | 0.82% | 38 |
|
|
2024
Q3 | $1.13M | Sell |
5,716
-36
| -0.6% | -$7.11K | 0.91% | 33 |
|
|
2024
Q2 | $987K | Buy |
5,752
+285
| +5% | +$48.9K | 0.85% | 43 |
|
|
2024
Q1 | $996K | Buy |
5,467
+28
| +0.5% | +$5.1K | 0.86% | 39 |
|
|
2023
Q4 | $843K | Sell |
5,439
-166
| -3% | -$25.7K | 0.8% | 43 |
|
|
2023
Q3 | $835K | Hold |
5,605
| – | – | 0.78% | 39 |
|
|
2023
Q2 | $755K | Sell |
5,605
-36
| -0.6% | -$4.85K | 0.76% | 46 |
|
|
2023
Q1 | $905K | Buy |
5,641
+870
| +18% | +$140K | 0.91% | 33 |
|
|
2022
Q4 | $775K | Buy |
4,771
+840
| +21% | +$136K | 0.87% | 36 |
|
|
2022
Q3 | $544K | Sell |
3,931
-112
| -3% | -$15.5K | 0.66% | 45 |
|
|
2022
Q2 | $621K | Buy |
4,043
+23
| +0.6% | +$3.53K | 0.74% | 41 |
|
|
2022
Q1 | $623K | Buy |
4,020
+177
| +5% | +$27.4K | 0.7% | 45 |
|
|
2021
Q4 | $522K | Buy |
+3,843
| New | +$522K | 0.45% | 64 |
|